Concurrence
PrivateLast Round
Series A
Mar 10, 2026
Total Funding Raised
$17.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Concurrence operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series A round in March 2026.
Concurrence is a healthcare technology company that develops AI-based clinical agent infrastructure to optimize healthcare delivery and patient engagement.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, NLP & Conversational AI, Healthcare Analytics, Data Integration, EHR & EMR
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Concurrence Comparables
Compare Concurrence with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hippocratic AI | 81% | |
| Sully.ai | 76% | |
| Ambience Healthcare | 76% |
For institutional investors. Book with your work email.
Concurrence Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 10, 2026 | ||||
| Seed | Jan 3, 2025 |
For institutional investors. Book with your work email.
Concurrence Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Coho Deeptech | Seed |
| GSV Ventures | Series A, Seed |
| Optum Ventures | Series A |
| General Catalyst | Series A, Seed |
| Madrona Venture Group | Series A |
| Comma Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 10, 2026
$11M round led by Madrona Venture Group.
- Jan 3, 2025
$6.3M round led by General Catalyst and GSV Ventures.
For institutional investors. Book with your work email.
Concurrence Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Concurrence's valuation, stock price, and market status.
Is Concurrence a public or private company?
Concurrence is a private company.
What is the current stock price of Concurrence?
Concurrence is a private company, so its shares have no public market price. Caplight tracks Concurrence's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Concurrence worth (valuation)?
Valuation information for Concurrence is not publicly available.
Can I buy Concurrence stock?
Concurrence shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Concurrence's last funding round?
Concurrence's most recent funding round was Series A on March 10, 2026.
Who are the main investors in Concurrence?
Key investors in Concurrence include GSV Ventures, General Catalyst, Madrona Venture Group.
Will Concurrence IPO soon?
No public IPO plans have been announced for Concurrence.
How can I track Concurrence secondary market activity?
Caplight tracks bids, offers, and trades in Concurrence's shares on secondary markets.